750308
Last Update Posted: 2014-12-18
Recruiting has ended
All Genders accepted | 18 Years-70 Years |
27 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i
This study will measure the effect of the agent tadalafil on glucose and insulin homeostasis in people with metabolic syndrome in the presence and absence of an ACE inhibitor.
Eligibility
Relevant conditions:
Metabolic Syndrome
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov